Zhou Chen, Liu Wen-Yuan, Feng Feng, Ye Hai, Wu Chun-Yong
Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing 211198, China.
Department of Natural Medicine Chemistry, China Pharmaceutical University, Nanjing 211198, China.
J Pharm Anal. 2013 Jun;3(3):168-172. doi: 10.1016/j.jpha.2013.01.003. Epub 2013 Jan 29.
YK-1101, with its structure as S-((E)-4-((7S,10S,Z)-4-ethylidene-7-isopropyl-2,5,8,12-tetraoxo -9-oxa-16-thia-3,6,13,18-tetraazabicyclo[13.2.1]octadeca-1(17),15(18)-dien-10-yl)but-3-en-1-yl) ethanethioate, is synthesized as a potential histone deacetylase inhibitor. Its quality and stability under various stress conditions are not fully understood. In this study, a high performance liquid chromatographic (HPLC) method was established and validated for the analysis of YK-1101 bulk drug samples. The chromatographic separation was performed on a C column with acetonitrile and water as mobile phase in a gradient elution. Based on the established method, the stability studies of YK-1101 under various stress conditions were carried out. YK-1101 was shown to undergo degradation under basic and acidic stress conditions, while it was stable under oxidative, photolytic and thermal conditions. In addition, a time of flight mass spectrometer (TOF/MS) was coupled to HPLC for the characterization of major degradation products produced under basic and acidic stress conditions. Their degradation pathways were also discussed.
YK-1101,其结构为S-((E)-4-((7S,10S,Z)-4-亚乙基-7-异丙基-2,5,8,12-四氧代-9-氧杂-16-硫杂-3,6,13,18-四氮杂双环[13.2.1]十八碳-1(17),15(18)-二烯-10-基)丁-3-烯-1-基)乙硫酯,作为一种潜在的组蛋白脱乙酰酶抑制剂被合成。其在各种应激条件下的质量和稳定性尚未完全明确。在本研究中,建立并验证了一种高效液相色谱(HPLC)法用于分析YK-1101原料药样品。色谱分离在C柱上进行,以乙腈和水为流动相进行梯度洗脱。基于所建立的方法,对YK-1101在各种应激条件下的稳定性进行了研究。结果表明,YK-1101在碱性和酸性应激条件下会发生降解,而在氧化、光解和热条件下是稳定的。此外,将飞行时间质谱仪(TOF/MS)与HPLC联用,对碱性和酸性应激条件下产生的主要降解产物进行了表征。还讨论了它们的降解途径。